Method for evaluating overall function of visual impairment crowd by using WHODAS 2.0
By using WHODAS2.0 tool to evaluate the overall function of people with visual impairment, the problem of inaccurate evaluation results in the prior art is solved, and the accuracy and effectiveness of functional evaluation of people with visual impairment is achieved. It is suitable for patients with low vision due to diabetes retinopathy. The quality of life and overall function assessment guides the improvement of low vision rehabilitation and quality of life.
Patent Information
- Application Number
- CN202311234867.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2023-09-25
- Publication Date
- 2024-11-08
AI Technical Summary
The prior art has problems with inaccurate results when evaluating the overall function of visually impaired populations, which is difficult to meet the actual needs of visually impaired populations.
The World Health Organization Disability Assessment Scale 2.0 (WHODAS2.0) tool is used to formulate evaluation standards based on the characteristics of people with visual impairment, and evaluate by determining the purpose of the evaluation, understanding the tools, preparing evaluation standards, conducting evaluations, calculating functional scores and analyzing and interpreting evaluations. As a result, the overall function of people with visual impairment was evaluated.
Through the WHODAS2.0 evaluation method, the functional evaluation results of people with visual impairment have good reliability and validity. They are suitable for evaluating the quality of life and overall function of low vision in diabetic retinopathy. They can describe the functional status in different dimensions and serve as low vision rehabilitation. The auxiliary assessment tool for efficacy has improved vision rehabilitation and quality of survival.
Smart Images

Figure SMS_1 
Figure SMS_2 
Figure SMS_3
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of evaluation systems, and in particular to a method for evaluating the overall function of visually impaired people by using WHODAS2.0. Background Art
[0002] The World Health Organization (WHO) reported in 2014 that there are 285 million visually impaired people in the world, of which 246 million are low-vision patients and 39 million are blind. Low vision refers to visual impairment that cannot be improved by surgery, medication or standard refractive correction, but the person can still use or have potential vision to participate in various work and activities. In 1987, my country formulated the standards for low vision and blindness: the best corrected visual acuity (BCVA) of the better eye of the two eyes is less than 0.3 and ≥ 0.05, and the BCVA of the better eye of the two eyes is less than 0.05 to light perception or visual field radius of less than 10° is considered blindness. With the continuous improvement of medical standards and the gradual improvement of specialized systems, the diagnostic standards for low vision have been continuously updated and aligned with international standards. In 2003, WHO proposed the use of presenting visual as the evaluation standard for visual impairment, and divided it into mild, moderate, severe visual impairment and blindness. Presenting visual impairment <0.5 is mild visual impairment, <0.3 is moderate visual impairment, <0.1 is severe visual impairment, and <0.05 is blind. Moderate and severe visual impairment is the traditional "low vision".
[0003] There are 1.35 million new low vision patients in my country every year, that is, about 3 low vision patients appear every minute. Low vision patients are more likely to have negative emotional reactions such as depression, anxiety, irritability, etc. than normal people. Therefore, they show behavioral reactions such as increased dependence, avoidance of social activities, and reduced interaction with others in daily social activities. The role changes caused by low vision seriously affect the quality of life of patients. According to the WHO report, the causes of low vision and blindness are similar. Globally, the main causes of visual impairment are uncorrected refractive error, untreated cataracts, age-related macular degeneration, glaucoma, diabetic retinopathy, corneal opacity, trachoma, etc. Among them, diabetic retinopathy (DR) is a common complication of DM and has become one of the four major blinding eye diseases in the world.
[0004] Diabetes mellitus (DM) is a complex metabolic disease. According to the latest data from the International Diabetes Federation (IDF), there were 387 million DM patients in the world in 2014. It is estimated that by 2035, the number will increase by 55%, and the total number will reach 600 million. Surveys and studies show that the prevalence of adult diabetes in my country was 12.8% in 2018. There are 130 million diabetic patients, about 30% of whom have diabetic retinopathy, and 33.3% of DR patients face blindness. Due to the dual pressure of physical and psychological pressure, DR low vision patients cannot play the corresponding roles and assume the due responsibilities in society and family, which seriously affects their status and interpersonal relationships in the family and society.
[0005] With the continuous progress of science, the rapid development of medicine and the change of health concepts, the medical model and the health concepts in people's minds have also changed. The medical model has changed from a single biomedical model to a "bio-psycho-social" medical model. In the diagnosis and treatment process, only treating the patient's eye condition is not comprehensive. At the same time, attention should be paid to the impact of the lesion on the patient's physical, psychological and social life. Studies have shown that the report results obtained through the quality of life questionnaire are helpful in formulating vision rehabilitation plans for low vision patients, and are also of great significance in evaluating treatment satisfaction and analyzing cost-effectiveness.
[0006] Questionnaires or scales are the main tools for understanding the quality of life related to visual function. The International Classification of Functioning, Disability and Health (ICF) constructs a new "bio-psycho-social" medical model based on the integrated model of function, disability and health. Its ultimate goal is to provide a unified and standardized language and framework for the classification of health status of the population worldwide to describe health status and issues related to health status. The World Health Organization Disability Assessment Schedule 2.0 (WHO DAS 2.0) is a functional assessment tool based on ICF. It is applicable to all diseases and can be used for people in different cultural environments. This scale assesses the functional status of six areas of the applicable population. It has been consistently confirmed to have good reliability and validity in many studies and is recommended by the International Classification of Disease version 11 (ICD-11) for overall functional evaluation. In addition, the survey tools related to visual function include: low vision quality of life questionnaire (LVQOL), vision related health quality of life questionnaire (VDQ), elderly low vision quality of life questionnaire and Chinese-version low vision quality of life questionnaire (CLVQOL). Among them, CLVQOL was translated based on the "Low Vision Quality of Life Scale" (LVQOL) and is currently widely used in domestic low vision outpatient clinics and rehabilitation practice and research.
[0007] At present, the overall functional assessment of the visually impaired mainly relies on conventional medical models and subjective judgment of individual needs. However, these methods have the problem of inaccurate assessment results and are difficult to meet the actual needs of the visually impaired. Summary of the invention
[0008] The purpose of the present invention is to provide a method for evaluating the overall function of visually impaired people using WHODAS2.0 to solve the problems raised in the above background technology.
[0009] To achieve the above object, the present invention provides the following technical solution: a method for evaluating the overall function of visually impaired people using WHODAS2.0, the method comprising the following steps:
[0010] A. Determine the purpose of the assessment: clarify the goal of assessing the overall function of people with visual impairment;
[0011] B. Understand WHODAS2.0 tool: Be familiar with the World Health Organization Disability Assessment Questionnaire, WHODAS2.0 version, and have a detailed understanding of the tool's usage, scoring criteria and calculation method;
[0012] C. Preparation of assessment standards: Based on the characteristics of the visually impaired population and in combination with the guidance of the WHODAS2.0 tool, develop assessment standards suitable for the visually impaired population;
[0013] D. Conduct assessment: Use the WHODAS2.0 tool and the compiled assessment criteria to assess the visually impaired population;
[0014] E. Calculate functional scores: According to the calculation method of WHODAS2.0, the scores of visually impaired people in various functional areas are calculated based on the collected assessment information;
[0015] F. Analyze and interpret the evaluation results: Analyze and interpret the evaluation results based on the calculated functional scores.
[0016] Preferably, in step A, the goal is to determine areas of their daily life that may be limited, and the areas include mobility, self-care and social interaction.
[0017] Preferably, in step D, relevant information is collected based on the assessment content, including the individual's functional performance, difficulties and limitations.
[0018] Preferably, in step F, the functional scores are compared with the scores of the general population or other disabled people to better understand the overall functional level of the visually impaired population.
[0019] Preferably, WHODAS2.0 internal consistency reliability analysis, WHODAS2.0 test-retest reliability analysis, WHODAS2.0 empirical validity analysis and WHODAS2.0 construct validity analysis are also included, and the WHODAS2.0 internal consistency reliability analysis is: the overall Cronbach's a coefficient of the scale is 0.951, and the Cronbach's a coefficient of the understanding and communication domain in the six dimensions is 0.773; the Cronbach's a coefficient of the moving around domain is 0.844; the Cronbachs a coefficient of the self-care domain is 0.838; the Cronbach's a coefficient of the getting along with others domain is 0.913; the Cronbach's a coefficient of the housework, work and study domain is 0.900; the Cronbach's a coefficient of the social participation domain is 0.914; the Cronbach's a coefficient of the social participation domain is 0.903; the Cronbach's a coefficient of the social participation domain is 0.916 ...73; the Cronbach's a coefficient of the social participation domain is 0.973; the Cronbach's a coefficient of the social participation domain is 0.973; the Cronbach's a coefficient of the social participation domain is 0. a coefficient = 0.903; WHODAS2.0 retest reliability analysis: two scores, T1 and T2 total score Pearson correlation coefficient is 1.000, six dimensions of the correlation coefficient > 0.990; WHODAS2.0 empirical validity analysis: WHODAS2.0 overall score and CLVQOL total score was significantly negatively correlated (r = -0.257, P < 0.01), among which, understanding and communication domain r = -0.440, moving around domain r = -0.263, self-care domain r = -0.520, getting along with others domain r = -0.275, housework, work domain r = -0.468, social participation domain r = -0.609; WHODAS2.0 construct validity analysis: confirmatory factor analysis results show that the average variance extracted value (average) of the six dimensions of the scale The variance extracted (AVE) was all > 0.5, and the construct reliability (CR) was all > 0.7. The confirmatory factor analysis preset model of the scale was further designed, and the results showed that the reliability coefficients of the 36 observed variables were all greater than 0.5, the CR values of the 6 latent variables were between 0.879-0.946, and the AVE values of each latent variable were between 0.552-0.795. The preset model was modified using AMOS software to establish the final model diagram. Finally, the square root values of the AVE of the 6 dimensions were between 0.743 and 0.892 for the discriminant validity analysis of the scale.
[0020] Preferably, vision rehabilitation training is also included, which includes the use of visual aids, daily life training and directional walking training, visual aids include optical visual aids, electronic visual aids and non-optical visual aids, optical visual aids include distance visual aids and near visual aids, and daily life training includes physical or basic daily life activities and instrumental daily life activities.
[0021] Preferably, the reliability test and validity test are also included. The reliability test includes homogeneity reliability and test-retest reliability. The validity test includes empirical validity and construct validity. Construct validity includes convergent validity, final model and discriminant validity. Homogeneity reliability is internal consistency reliability, which is used to test the consistency reliability of all items in the scale. Homogeneity reliability includes: (1) mean inter-item correlation coefficient: refers to the mean inter-item correlation coefficient between each factor and the full scale, which is used to test the homogeneity of the scale; (2) Cronbach'α coefficient: Cronbach'α>0.9, the consistency of the scale is very good; Cronbach'α>0.8, the consistency of the scale is very good; Cronbach'α>0.7, the consistency of the scale is acceptable; (3) split-half reliability: the split-half correlation coefficient between each factor and the full scale; test-retest reliability (retest reliability) Reliability) is used to test the stability and consistency of the scale over time; criterion validity refers to the degree of association between a test or scale and an external criterion. Construct validity includes convergent validity, final model, and discriminant validity. Construct validity is tested by confirmatory factor analysis (CFA). Convergent validity is tested by CFA of the WHODAS2.0 scale using SPSS software. The final model is further designed by SPSS software. The CFA preset model of the WHODAS2.0 scale is used with 36 items as observed variables and 6 dimensions as latent variables. Discriminant validity is analyzed on the scale.
[0022] Preferably, the data is reviewed after the scale is recovered to ensure accurate data entry. To ensure the quality of data entry, the "two-person independent entry" method is implemented. Before data analysis, the entered data is logically checked, checked for errors, and filled in. After ensuring that the data is accurate, it is quantified. The acquired data is entered and a database is established using Excel software. SPSS software is used to perform statistical analysis on the data, and Highcharts software is used for drawing.
[0023] The specific methods are as follows: (1) Descriptive statistics of mean, standard deviation and constituent ratio were used to analyze the general characteristics of 120 DR low vision patients, such as gender, age, duration of diabetes, education level, and glucose control methods;
[0024] (2) Reliability analysis: Cronbach's α coefficient was used to analyze the internal consistency reliability of WHODAS2.0; Pearson correlation coefficient was used to analyze the test-retest reliability of WHODAS2.0;
[0025] (3) Validity analysis: Pearson correlation coefficient was used to test the empirical validity of the scale; confirmatory factor analysis (CFA) was used to test the construct validity of the scale - SPSS software was used to perform a confirmatory factor analysis on the scale to set the preset model, and the preset model was further modified using AMOS software to establish the final model for convergent validity confirmation analysis; finally, SPSS software was used to perform discriminant validity analysis on the scale;
[0026] (4) Use quantile-quantile plots (QQ plots) to test the normality of continuous data, such as the distribution of WHODAS2.0 scores in patients with DR and low vision; when continuous variables conform to normal distribution, the mean ± standard deviation is used to describe them, otherwise the median M is used to describe them;
[0027] (5) ANOVA (one-way ANOVA) was used to study the differences between the demographic characteristics and the dimensions. Finally, a linear regression analysis was performed on the correlated characteristics and the total score of the scale.
[0028] Compared with the prior art, the present invention has the following beneficial effects:
[0029] The present invention uses WHODAS2.0 to evaluate the overall function of visually impaired people. By determining the evaluation purpose, compiling evaluation standards, calculating functional scores, and analyzing and interpreting evaluation results, the evaluation results have good reliability and validity. WHODAS2.0 is suitable for evaluating the quality of life and overall function of diabetic retinopathy low vision patients, and has good reliability and validity. The course of diabetes has a significant positive effect on the overall function of diabetic retinopathy low vision patients. The lower the best corrected visual acuity, the worse the overall functional evaluation of diabetic retinopathy low vision patients. The functional status of diabetic retinopathy low vision patients can be described in different dimensions, and it can also be used as an auxiliary evaluation tool for the therapeutic effect of low vision rehabilitation. It is worthy of in-depth research and discussion to establish a low vision rehabilitation database based on WHODAS2.0. By establishing WHODAS2.0 with diabetic retinopathy low vision people as the focus, based on the ICF concept, it is attempted to use WHODAS2.0 to evaluate the overall function of DR low vision patients for the first time. With the help of the functional evaluation scale survey tool, it has guiding significance in the visual rehabilitation and quality of life improvement of DR low vision people. BRIEF DESCRIPTION OF THE DRAWINGS
[0030] Figure 1 This is the final model diagram of the present invention. DETAILED DESCRIPTION
[0031] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0032] See also Figure 1 A method for evaluating the overall function of visually impaired people using WHODAS2.0, the method comprising the following steps:
[0033] A. Determine the purpose of the assessment: clarify the goal of assessing the overall function of people with visual impairment;
[0034] B. Understand the WHODAS2.0 tool: Be familiar with the WHO Disability Assessment Questionnaire, WHODAS2.0 version, which is designed to assess the degree of functional impairment of individuals in various areas, and have a detailed understanding of the tool's usage, scoring criteria and calculation methods;
[0035] C. Preparation of evaluation criteria: Based on the characteristics of the visually impaired population and in combination with the guidance of the WHODAS2.0 tool, develop evaluation criteria applicable to the visually impaired population to ensure that the evaluation criteria are credible and effective;
[0036] D. Conduct assessment: Use the WHODAS2.0 tool and the compiled assessment criteria to assess the visually impaired population;
[0037] E. Calculate functional scores: According to the calculation method of WHODAS2.0, the scores of visually impaired people in various functional areas are calculated based on the collected assessment information. The scores can reflect the overall functional level of the individual and the degree of functional impairment in different areas;
[0038] F. Analyze and interpret the evaluation results: Analyze and interpret the evaluation results based on the calculated functional scores.
[0039] WHODAS2.0 is used to evaluate the overall function of people with visual impairment. By determining the purpose of the evaluation, compiling the evaluation criteria, calculating the functional scores, and analyzing and interpreting the evaluation results, the evaluation results have good reliability and validity. WHODAS2.0 is suitable for evaluating the quality of life and overall function of patients with diabetic retinopathy and low vision, and has good reliability and validity. The course of diabetes has a significant positive effect on the overall function of patients with diabetic retinopathy and low vision. The lower the best corrected visual acuity, the worse the overall functional evaluation of patients with diabetic retinopathy and low vision. The functional status of patients with diabetic retinopathy and low vision can be described in different dimensions, and it can also be used as an auxiliary evaluation tool for the efficacy of low vision rehabilitation. It is worthy of in-depth study and discussion to establish a low vision rehabilitation database based on WHODAS2.0.
[0040] In step A, the goal is to identify areas of their daily life that may be limited, and areas include mobility, self-care, and social interaction.
[0041] In step D, relevant information is collected based on the assessment content, including the individual's functional performance, difficulties and limitations.
[0042] In step F, functional scores are compared with scores from the general population or other groups with disabilities to better understand the overall functional level of the visually impaired population.
[0043] The quality of life of diabetic patients varies depending on whether they have complications and the degree of complications. Through the analysis of the total score and the scores of each dimension of WHODAS2.0, the total score and the scores of each dimension of WHODAS2.0 conform to the normal distribution. 95.83% of DR low vision patients have different degrees of functional loss, which is positively correlated with the evaluation research of diabetes quality of life
[61] , DR quality of life
[62] and low vision quality of life
[63] , and has reference significance. At the same time, in the classification of the overall score functional loss level, 80 patients (accounting for 66.67%) were found to have level 4 functional loss, indicating that the overall function of DR low vision patients is impaired, but not serious overall. Among them, the average scores of individual items in the two areas of housework activities, work study and social participation of DR low vision people are significantly higher than those in other areas, indicating that the overall functional impairment of DR low vision people is more prominent in the two areas of housework activities, work study and social participation. This finding fully reflects the significance of using WHODAS2.0 to evaluate the overall function of DR low vision people. In this study, the correlation analysis between samples of different ages and the overall and dimensional scores of WHODAS2.0 showed that the age group ≥71 years old had the worst functional evaluation in the two areas of understanding and communication and getting around; at the same time, the correlation analysis between different occupational status and the overall and dimensional scores of WHODAS2.0 showed that the retired group had the worst functional evaluation in the three areas of understanding and communication, self-care and getting along with others, which is consistent with the results of relevant domestic studies [66-67]. In the assessment of the activities of daily life (ADL) of people with low vision, the Barthel index is often used to assess basic or physical ADL (BADL / PADL), while the functional activities questionary (FAQ) and the rapid disability rating scale (RDRS) are used to assess instrumental ADL (LADL). In both BADL / PADL and LDAL studies, it was found that the lower the vision of the visually impaired people, the lower their daily activities
[68] . In this study, the group with BCVA ≥ 0.02 and < 0.05 had the worst performance in the six dimensions and overall functional assessment. This finding is similar to that of similar studies in China
[69] .In the linear regression analysis between the characteristics with significant differences and the total score, it was found that the course of DM had a significant positive impact on the total score, that is, the longer the course of DM, the worse the overall function of DR low vision, which is in the same direction as the relevant research report on the quality of life scale for patients with diabetes mellitus (DMQLS)
[70] . It can be seen that WHODAS2.0 can not only be used to evaluate the overall functional status of DR low vision people and indirectly reflect the quality of life of DR low vision patients, but also be used to evaluate the impact of the disease on patients, help find the main areas related to the quality of life of DR low vision patients, such as housework, work and study, and social participation, which is conducive to taking targeted protective measures and providing a basis for improving the rehabilitation care level and quality of life of DR low vision patients; at the same time, combined with the WHODAS2.0 survey, it may be possible to evaluate DR clinical treatments and intervention measures in the future, find the focus of low vision rehabilitation, and ultimately achieve the goal of improving the quality of life of patients. In summary, WHODAS2.0 is a universal and standardized disability assessment tool that is applicable to various diseases in cross-cultural contexts, including disabilities caused by mental disorders, organic disorders, and addiction disorders. This study suggests that WHODAS2.0 can describe the functional status of patients with low vision due to diabetic retinopathy in different dimensions, and can also be used as an auxiliary assessment tool for the efficacy of low vision rehabilitation. The establishment of a low vision rehabilitation database based on WHODAS2.0 is worthy of in-depth study and discussion.
[0044] The innovations of this study are as follows: (1) Focusing on the diabetic retinopathy low vision population, based on the ICF concept, this study attempted to use WHODAS2.0 for the first time to evaluate the overall function of DR low vision patients; (2) With the help of the functional assessment scale survey tool, it has guiding significance in the visual rehabilitation and quality of life improvement of DR low vision population.
[0045] Diabetic retinopathy causes:
[0046] 1. WHODAS2.0 is a mature assessment scale for overall functional evaluation and is used to evaluate the overall functional status of patients with diabetic retinopathy and low vision, with good reliability and validity;
[0047] 2. The duration of diabetes has a significant positive impact on the overall function of DR low vision patients;
[0048] 3. The lower the best corrected visual acuity, the worse the overall functional assessment of DR low vision patients.
[0049] It also includes WHODAS2.0 internal consistency reliability analysis, WHODAS2.0 test-retest reliability analysis, WHODAS 2.0 empirical validity analysis and WHODAS2.0 construct validity analysis. The WHODAS2.0 internal consistency reliability analysis is as follows: the overall Cronbach's a coefficient of the scale is 0.951, and the Cronbach's a coefficient of the understanding and communication domain in the six dimensions is 0.773; the Cronbach's a coefficient of the moving around domain is 0.844; the Cronbachs a coefficient of the self-care domain is 0.838; the Cronbach's a coefficient of the getting along with others domain is 0.913; the Cronbach's a coefficient of the housework, work and study domain is 0.900; the Cronbach's a coefficient of the social participation domain is 0.914. a coefficient = 0.903; WHODAS2.0 retest reliability analysis: two scores, T1 and T2 total score Pearson correlation coefficient is 1.000, six dimensions of the correlation coefficient > 0.990; WHODAS2.0 empirical validity analysis: WHODAS2.0 overall score and CLVQOL total score was significantly negatively correlated (r = -0.257, P < 0.01), among which, understanding and communication domain r = -0.440, moving around domain r = -0.263, self-care domain r = -0.520, getting along with others domain r = -0.275, housework, work domain r = -0.468, social participation domain r = -0.609; WHODAS2.0 construct validity analysis: confirmatory factor analysis results show that the average variance extracted value (average) of the six dimensions of the scale The variance extracted (AVE) was all > 0.5, and the construct reliability (CR) was all > 0.7. The confirmatory factor analysis preset model of the scale was further designed, and the results showed that the reliability coefficients of the 36 observed variables were all greater than 0.5, the CR values of the 6 latent variables were between 0.879-0.946, and the AVE values of each latent variable were between 0.552-0.795. The preset model was modified using AMOS software to establish the final model diagram. Finally, the square root values of the AVE of the 6 dimensions were between 0.743 and 0.892 for the discriminant validity analysis of the scale.
[0050] It also includes vision rehabilitation training, which includes the use of visual aids, daily life training and directional walking training. Visual aids include optical aids, electronic aids and non-optical aids. Optical aids include distance aids and near aids. Daily life training includes physical or basic daily life activities and instrumental daily life activities.
[0051] It also includes reliability test and validity test. Reliability test includes homogeneity reliability and test-retest reliability. Validity test includes empirical validity and construct validity. Construct validity includes convergent validity, final model and discriminant validity. Homogeneity reliability is internal consistency reliability, which is used to test the consistency reliability of all items in the scale. Homogeneity reliability includes: (1) mean inter-item correlation coefficient: refers to the mean inter-item correlation coefficient between each factor and the full scale, which is used to test the homogeneity of the scale; (2) Cronbach's α coefficient: Cronbach's α>0.9, the consistency of the scale is very good; Cronbach's α>0.8, the consistency of the scale is very good; Cronbach's α>0.7, the consistency of the scale is acceptable; (3) Split-half reliability: the split-half correlation coefficient between each factor and the full scale; This study used Cronbach's α coefficient to analyze the internal consistency reliability of the WHODAS2.0 scale. The results are as follows: WHO The overall Cronbach's α coefficient of DAS2.0 is 0.951. Among the six dimensions, the Cronbach's α coefficient of the understanding and communication domain is 0.773; the Cronbach's α coefficient of the moving around domain is 0.844; the Cronbach's α coefficient of the self-care domain is 0.838; the Cronbach's α coefficient of the getting along with others domain is 0.913; the Cronbach's α coefficient of the housework, work and study domain is 0.9; the Cronbach's α coefficient of the social participation domain is 0.903; In summary: the overall consistency of the three domains of getting along with others, housework, work and study, and social participation and WHODAS2.0 is very good; the consistency of the two domains of moving around and self-care is very good; the consistency of the understanding and communication domain is acceptable; the retest reliability (retest reliability The reliability of the scale was used to test the stability and consistency of the scale over time. In this study, the subjects took the WHODAS2.0 retest (T2) 10 days after completing the first test (T1). The Pearson product-moment correlation coefficient between T1 and T2 was the test-retest reliability coefficient. The Pearson correlation coefficient of the total score of the scale was 1.000 for the two scores, and the correlation coefficients of the six dimensions were all >0.990. The results showed that the WHODAS2.0 scale had high temporal stability and consistency. Criterion validity refers to the degree of correlation between a test or scale and an external criterion. If the correlation between a test or scale and an external criterion is higher, it means that the criterion validity of this test or scale is higher, and the criterion scale itself should also have high reliability and validity. CLVQOL is a mature standard scale in the assessment of low vision patients. This study used it as a criterion for validity testing. The results showed that the overall score of WHODAS2.0 was significantly negatively correlated with the total score of CLVQOL (r=-0.257, P < 0.01), among which, r = -0.440 in the domain of understanding and communication, r = -0.263 in the domain of moving around, r = -0.520 in the domain of self-care, r = -0.275 in the domain of getting along with others, r = -0.468 in the domain of housework and work, and r = -0.609 in the domain of social participation. That is, the six dimensions in WHODAS2.0 are all significantly negatively correlated with the total score of CLVQOL. The results show that the scale has good validity, as shown in the following table (correlation coefficients between the total score of WHODAS2.0 and the six dimensions and CLVQOL):
[0052]
[0053] Construct validity includes convergent validity, final model, and discriminant validity. Construct validity was tested by confirmatory factor analysis (CFA). Convergent validity was tested by SPSS software for CFA of WHODAS2.0. The analysis results showed that the six dimensions corresponded to six factors, and the average variance extracted (AVE) of each factor was greater than 0.5, and the construct reliability (CR) was greater than 0.7. The results showed that the WHODAS2.0 scale used in this study had good convergent validity, as shown in the following table (WHODAS2.0 model AVE and CR indicator results):
[0054]
[0055] The final model was further designed by SPSS software. The CFA preset model of the WHODAS2.0 scale was used, with 36 items as observed variables and 6 dimensions as latent variables. The analysis results showed that the standardized factor loading between the latent variables and the corresponding measurement indicators was between 0.620-0.996, and the standard error was between 0.030-0.776, as shown in the following table (WHODAS2.0 scale factor loading coefficient table):
[0056]
[0057] Based on the CFA model preset by SPSS and combined with the theoretical feasibility of WHODAS2.0, the preset model was further modified by AMOS software according to the correction index. The final model is as follows Figure 1 .
[0058] Discriminant validity The discriminant validity analysis of the scale showed that the AVE square root values of the six dimensions were all greater than the maximum absolute value of the correlation coefficient between the factors. The research results showed that the WHODAS2.0 scale has good discriminant validity.
[0059] Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that various changes, modifications, substitutions and variations may be made to the embodiments without departing from the principles and spirit of the present invention, and that the scope of the present invention is defined by the appended claims and their equivalents.
Claims
1. A method for evaluating the overall function of visually impaired people using WHODAS2.0, characterized in that: The method comprises the following steps: A. Determine the purpose of the assessment: clarify the goal of assessing the overall function of people with visual impairment; B. Understand WHODAS2.0 tool: Be familiar with the World Health Organization Disability Assessment Questionnaire, WHODAS2.0 version, and have a detailed understanding of the tool's usage, scoring criteria and calculation method; C. Preparation of assessment standards: Based on the characteristics of the visually impaired population and in combination with the guidance of the WHODAS2.0 tool, develop assessment standards suitable for the visually impaired population; D. Conduct assessment: Use the WHODAS2.0 tool and the compiled assessment criteria to assess the visually impaired population; E. Calculate functional scores: According to the calculation method of WHODAS2.0, the scores of visually impaired people in various functional areas are calculated based on the collected assessment information; F. Analyze and interpret the evaluation results: Analyze and interpret the evaluation results based on the calculated functional scores.
2. The method for evaluating the overall function of visually impaired people using WHODAS2.0 according to claim 1, characterized in that: In step A, the goal is to identify areas of their daily life that may be limited, and areas include mobility, self-care, and social interaction.
3. The method for evaluating the overall function of visually impaired people using WHODAS2.0 according to claim 1, characterized in that: In step D, relevant information is collected based on the assessment content, including the individual's functional performance, difficulties and limitations.
4. The method for evaluating the overall function of visually impaired people using WHODAS2.0 according to claim 1, characterized in that: In step F, the functional scores are compared with the scores of the general population or other disabled people to better understand the overall functional level of the visually impaired population.
5. The method for evaluating the overall function of visually impaired people using WHODAS2.0 according to claim 1, characterized in that: It also includes WHODAS2.0 internal consistency reliability analysis, WHODAS 2.0 test-retest reliability analysis, WHODAS2.0 empirical validity analysis and WHODAS2.0 construct validity analysis. The WHODAS2.0 internal consistency reliability analysis is as follows: the overall Cronbach's a coefficient of the scale is 0.951, and the Cronbach's a coefficient of the understanding and communication domain in the six dimensions is 0.773; the Cronbach's a coefficient of the moving around domain is 0.844; the Cronbachs a coefficient of the self-care domain is 0.838; the Cronbach's a coefficient of the getting along with others domain is 0.913; the Cronbach's a coefficient of the housework, work and study domain is 0.900; the Cronbach's a coefficient of the social participation domain is 0.
914. a coefficient = 0.903; WHODAS2.0 retest reliability analysis: two scores, T1 and T2 total score Pearson correlation coefficient is 1.000, the correlation coefficient of the six dimensions are > 0.990; WHODAS2.0 empirical validity analysis: WHODAS2.0 overall score and CLVQOL total score are significantly negatively correlated, among which, r = -0.440 in the understanding and communication domain, r = -0.263 in the moving around domain, r = -0.520 in the self-care domain, r = -0.275 in the getting along with others domain, r = -0.468 in the housework and work domain, and r = -0.609 in the social participation domain. ; The construct validity analysis of WHODAS2.0 is as follows: the results of confirmatory factor analysis show that the average variance extraction values corresponding to the six dimensions of the scale are all >0.5, and the combined reliability values are all >0.7; the confirmatory factor analysis preset model of the scale is further designed, and the results show that the reliability coefficients of the 36 observed variables are all greater than 0.5, the CR values of the six latent variables are between 0.879-0.946, and the AVE values of each latent variable are between 0.552-0.795; the preset model is modified using AMOS software to establish the final model diagram; finally, the AVE square root values of the six dimensions of the scale discriminant validity analysis are between 0.743-0.
892.
6. The method for evaluating the overall function of visually impaired people using WHODAS2.0 according to claim 1, characterized in that: It also includes vision rehabilitation training, which includes the use of visual aids, daily life training and directional walking training. Visual aids include optical aids, electronic aids and non-optical aids. Optical aids include distance aids and near aids. Daily life training includes physical or basic daily life activities and instrumental daily life activities.
7. The method for evaluating the overall function of visually impaired people using WHODAS2.0 according to claim 1, characterized in that: It also includes reliability test and validity test. Reliability test includes homogeneity reliability and test-retest reliability. Validity test includes empirical validity and construct validity. Construct validity includes convergent validity, final model and discriminant validity. Homogeneity reliability is internal consistency reliability, which is used to test the consistency reliability among all items of the scale. Homogeneity reliability includes: (1) Average correlation coefficient between items: refers to the average correlation coefficient between items of each factor and the full scale, which is used to test the homogeneity of the scale; (2) Cronbach's α coefficient: Cronbach's α>0.9, the consistency of the scale is very good; Cronbach's α>0.8, the consistency of the scale is very good; Cronbach's α>0.7, the consistency of the scale is acceptable; (3) Split-half reliability: the split-half correlation coefficient between each factor and the full scale; Test-retest reliability is used to examine the stability and consistency of the scale over time; Criterion validity refers to the degree of correlation between a test or scale and an external criterion. Construct validity includes convergent validity, final model, and discriminant validity. Construct validity is tested by confirmatory factor analysis. Convergent validity is tested by CFA of the WHODAS2.0 scale using SPSS software. The final model is further designed by SPSS software. The CFA preset model of the WHODAS2.0 scale is used, with 36 items as observed variables and 6 dimensions as latent variables. Discriminant validity is tested by discriminant validity analysis of the scale.
8. The method for evaluating the overall function of visually impaired people using WHODAS2.0 according to claim 5, characterized in that: After the scale is collected, the data is reviewed to ensure accurate data entry. To ensure the quality of data entry, the "two-person independent entry" method is implemented. Before data analysis, the entered data is logically checked, checked for errors, and filled in. After ensuring that the data is accurate, it is quantified. Excel software is used to enter the acquired data and establish a database. SPSS software is used to perform statistical analysis on the data, and Highcharts software is used to complete the drawing. The specific methods are as follows: (1) Descriptive statistics of mean, standard deviation and constituent ratio were used to analyze the general characteristics of 120 DR low vision patients, such as gender, age, duration of diabetes, education level, and glucose control methods; (2) Reliability analysis: Cronbach's α coefficient was used to analyze the internal consistency reliability of WHODAS2.0; Pearson correlation coefficient was used to analyze the test-retest reliability of WHODAS2.0; (3) Validity analysis: Pearson correlation coefficient was used to test the empirical validity of the scale; confirmatory factor analysis (CFA) was used to test the construct validity of the scale - SPSS software was used to perform a confirmatory factor analysis on the scale to set the preset model, and the preset model was further modified using AMOS software to establish the final model for convergent validity confirmation analysis; finally, SPSS software was used to perform discriminant validity analysis on the scale; (4) The quantile-quantile plot (QQ plot) was used to test the normality of continuous data and the distribution of WHODAS2.0 scores in patients with DR and low vision; When continuous variables conform to normal distribution, mean ± standard deviation is used to describe them, otherwise median M is used to describe them; (5) ANOVA (one-way ANOVA) was used to study the differences between the demographic characteristics and the dimensions. Finally, a linear regression analysis was performed on the correlated characteristics and the total score of the scale.
